A guiding principle of ethical medical research today is justice: the fair distribution of costs and benefits to potential research participants.
But as we examine the current lack of diversity in clinical trials, we have to ask: are research opportunities being distributed fairly? And can alternative clinical trials models, such as decentralized trials, help tip the scales towards attaining distributive justice?
This whitepaper provides a snapshot of the current state of diversity in clinical trials, then explores whether the alternative clinical trial approaches necessitated by the COVID-19 pandemic might ensure that more potential research participants have fair access to clinical trials.
Download our whitepaper to learn more.